Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?
The Journal of Clinical Hypertension · 2024
DOI: 10.1111/jch.14898 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Hypertension, 2024. Verfasst von Houry Puzantian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hariri School of Nursing, American University of Beirut, Beirut, Lebanon. Hauptthemen laut MEDLINE: Aldosterone, Obesity, Receptors, Mineralocorticoid, Hypertension. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The obesity pandemic, with its associated comorbidities of hypertension and diabetes, constitutes a global public health issue. Importantly, there is an increasing prevalence of aldosterone excess related to obesity and resultant poor health outcomes. Nevertheless, the association between aldosterone and obesity still needs to be clarified. In this review, the authors discuss the role of white adipose tissue in linking obesity, aldosterone excess, and hypertension. The consequences of aldosterone excess in obesity are presented as genomic, non‐genomic, and non‐epithelial effects. Moreover, the authors emphasize the value of interference with aldosterone pathophysiology (as with mineralocorticoid antagonists) in obesity, thus reducing the adverse clinical impact of aldosterone in myocardial infarction, heart failure, kidney dysfunction, and associated mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hariri School of Nursing, American University of Beirut, Beirut, Lebanon.
- Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
- Department of Medicine, Division of Renal, Electrolyte and Hypertension, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Medicine, Division of Nephrology, University of Texas Health San Antonio, San Antonio, Texas, USA.
Zitieren
APA
Puzantian, H., Townsend, R., & Bansal, S. (2024). Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14898
Vancouver
Puzantian H, Townsend R, Bansal S. Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?. The Journal of Clinical Hypertension. 2024. doi:10.1111/jch.14898
BibTeX
@article{Puzantian2024,
author = {Puzantian, Houry and Townsend, Raymond and Bansal, Shweta},
title = {Obesity, aldosterone excess, and mineralocorticoid receptor activation: Parallel or intersected circumstances?},
journal = {The Journal of Clinical Hypertension},
year = {2024},
doi = {10.1111/jch.14898}
}
EUVIMED